Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, February 2008, p. 570-573, Vol. 52, No. 2
0066-4804/08/$08.00+0 doi:10.1128/AAC.01114-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Antimicrobial Activities of Tigecycline and Other Broad-Spectrum Antimicrobials Tested against Serine Carbapenemase- and Metallo-β-Lactamase-Producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program
Mariana Castanheira,1*
Hélio S. Sader,1,2
Lalitagauri M. Deshpande,1
Thomas R. Fritsche,1 and
Ronald N. Jones1,3
JMI Laboratories, North Liberty, Iowa 52317,1
Universidade Federal de Sao Paulo, Sao Paulo, Brazil,2
Tufts University School of Medicine, Boston, Massachusetts 021113
Received 23 August 2007/
Returned for modification 23 October 2007/
Accepted 23 November 2007
A total of 104 carbapenemase (serine- and metallo-β-lactamase [MβL])-producing strains of the Enterobacteriaceae family collected from 2000 to 2005 in medical centers distributed worldwide were tested against tigecycline and 25 comparators by reference broth microdilution methods. The most frequent carbapenemase was KPC-2 or -3 (73 strains), followed by VIM-1 (14), IMP-1 (11), SME-2 (5), and NMC-A (1). All serine carbapenemases were detected in the United States, while MβL-producing strains were isolated in Europe. Carbapenemase-producing Enterobacteriaceae showed high rates of resistance to most antimicrobial agents tested. The rank order of in vitro activity against these strains was as follows: tigecycline (100.0% susceptible) > polymyxin B (88.1%) > amikacin (73.0%) > imipenem (37.5%). Tigecycline was very active (MIC90, 1 µg/ml) against this significant, contemporary collection of well-characterized strains and appears to be an excellent option compared to the polymyxins for treatment of infections caused by these multidrug-resistant Enterobacteriaceae.
* Corresponding author. Mailing address: 345 Beaver Kreek Centre, Suite A, North Liberty, IA 52317. Phone: (319) 665-3370. Fax: (319) 665-3371. E-mail:
mariana-castanheira{at}jmilabs.com
Published ahead of print on 10 December 2007.
Antimicrobial Agents and Chemotherapy, February 2008, p. 570-573, Vol. 52, No. 2
0066-4804/08/$08.00+0 doi:10.1128/AAC.01114-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Shen, P., Wei, Z., Jiang, Y., Du, X., Ji, S., Yu, Y., Li, L.
(2009). Novel Genetic Environment of the Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob. Agents Chemother.
53: 4333-4338
[Abstract]
[Full Text]
-
Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R., Bonomo, R. A.
(2009). Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System. Antimicrob. Agents Chemother.
53: 3628-3634
[Abstract]
[Full Text]
-
Nicasio, A. M., Crandon, J. L., Nicolau, D. P.
(2009). In Vivo Pharmacodynamic Profile of Tigecycline against Phenotypically Diverse Escherichia coli and Klebsiella pneumoniae Isolates. Antimicrob. Agents Chemother.
53: 2756-2761
[Abstract]
[Full Text]
-
Lee, J., Patel, G., Huprikar, S., Calfee, D. P., Jenkins, S. G.
(2009). Decreased Susceptibility to Polymyxin B during Treatment for Carbapenem-Resistant Klebsiella pneumoniae Infection. J. Clin. Microbiol.
47: 1611-1612
[Full Text]
-
Wolter, D. J., Kurpiel, P. M., Woodford, N., Palepou, M.-F. I., Goering, R. V., Hanson, N. D.
(2009). Phenotypic and Enzymatic Comparative Analysis of the Novel KPC Variant KPC-5 and Its Evolutionary Variants, KPC-2 and KPC-4. Antimicrob. Agents Chemother.
53: 557-562
[Abstract]
[Full Text]
-
Bennett, J. W., Herrera, M. L., Lewis, J. S. II, Wickes, B. W., Jorgensen, J. H.
(2009). KPC-2-Producing Enterobacter cloacae and Pseudomonas putida Coinfection in a Liver Transplant Recipient. Antimicrob. Agents Chemother.
53: 292-294
[Abstract]
[Full Text]
-
Kelesidis, T., Karageorgopoulos, D. E., Kelesidis, I., Falagas, M. E.
(2008). Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother
62: 895-904
[Abstract]
[Full Text]
-
Hawkey, P. M.
(2008). The growing burden of antimicrobial resistance. J Antimicrob Chemother
62: i1-i9
[Abstract]
[Full Text]
-
Landman, D., Georgescu, C., Martin, D. A., Quale, J.
(2008). Polymyxins Revisited. Clin. Microbiol. Rev.
21: 449-465
[Abstract]
[Full Text]